Form D · Biotechnology
AcuraStem Inc
Pasadena, CA · CIK 0001745880
Offering snapshot reported Jun 22, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 22, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 30, 2022 | Initial | $3,110,332 | No comparison | 1 | SEC filing |
| Nov 22, 2022 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Jun 19, 2019 | Amendment | $380,000 | $330,000vs Jul 12, 2018 | 1 | SEC filing |
| Jul 12, 2018 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-588001
Convertible promissory note
Source: Form D, filed Jun 22, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Alworth | Director, Executive |
| Paul August | Director |
| Justin Ichida | Director |
| Qing Liu Michael | Director |
| Marcel Van Der Brug | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
150 North Orange Grove Blvd. Suite 220
Pasadena, CA, 91103
Pasadena, CA, 91103